Name | RUA Life Sciences |
---|---|
Epic | RUA |
Isin | GB0033360586 |
Industry | Medical Equipment and Services |
Latest share price | 10.75p | Net gearing | n/a |
---|---|---|---|
Market capitalisation | £6.67 | Debt ratio | n/a |
Shares in issue | 62.06 | Debt-to-equity ratio | n/a |
P/E ratio | n/a | Assets / equity ratio | n/a |
Total dividends per share | n/a | Price to book value | n/a |
Dividend yield | n/a | ROCE | -51.57 |
Dividend cover | n/a | EPS growth | n/a |
Earning per share | -9.03 | 52-week high / low | 8.75p / 37.50p |
Type | Ex-date | Pay-date | Net-dividend |
---|---|---|---|
No dividends declared |
Company name | RUA Life Sciences |
---|---|
Address | 163 Bath Street, Glasgow, United Kingdom, G2 4SQ |
Telephone | |
Website | http://rualifesciences.com/ |
Director | Position |
---|---|
Mr Lachlan Smith | CFO |
Mr William D Brown | Chairman |
Mr John McKenna | Executive Director |
Mr Ian Ardill | Independent Non-Executive Director |
Mr Geoffrey Alan Berg | Independent Non-Executive Director |
Mr John Louis Ely | Independent Non-Executive Director |
Assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Reporting date | 31/03/23 | 31/03/22 | 31/03/21 |
Intangible asssets and goodwill | 0.77 | 0.82 | 0.88 |
Investments and other non-current assets | n/a | n/a | n/a |
Total non-current assets | 3.51 | 3.42 | 2.83 |
Inventory / work in progress | 0.08 | 0.12 | 0.09 |
Trade and other receivables | 0.59 | 1.12 | 0.95 |
Cash and equivalents | 1.48 | 2.96 | 6.29 |
Other current assets and asset held for resale | n/a | n/a | n/a |
Total of all assets | 5.66 | 7.63 | 10.15 |
Liabilities £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Short term liabilities | 0.41 | 0.51 | 1.1 |
Long term liabilities | 0.57 | 0.53 | 0.55 |
Other liabilites / pension etc | n/a | n/a | n/a |
Total of all liabilities | 0.98 | 1.04 | 1.65 |
Net assets £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Net assets | 4.68 | 6.58 | 8.51 |
Equity £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Share capital | 1.11 | 1.11 | 12.95 |
Minority interests | n/a | n/a | n/a |
Retained earnings | -18.55 | -16.54 | -14.47 |
Share premium account | 11.73 | 11.73 | 11.73 |
Total equity | 4.68 | 6.58 | 8.51 |
Income £ (m) | 2023 | 2022 | 2021 |
---|---|---|---|
Turnover | n/a | n/a | n/a |
Operating profit | -2.31 | -2.35 | -1.55 |
Pre-tax profit | -2.32 | -2.36 | -1.59 |